comparemela.com

Latest Breaking News On - Allison deangelis - Page 4 : comparemela.com

Pitch Deck: 64x Bio Raises $55 Million for Cell, Gene Therapy Tools

Hundreds of cell and gene therapies are being held up because of difficulty manufacturing components. Here's the solution 64x Bio pitched to investors.

Pitch decksGene therapyCell therapyBi primeAllison deangelis

Medicare Wants to Limit Biogen s Alzheimer s Drug Aduhelm to Trial Participants

The guidance is a blow for Biogen, which has struggled with sales of its new drug after a controversial FDA approval.

Alzheimer x27s diseaseMedicare advantageHealth insuranceAllison deangelis

List: 10 Biotech Takeover Targets for Pharma M&a in 2022

Analysts and investors think drug companies could spend up to $1.6 trillion on M&A this year. Here are the 10 companies they agree are up for grabs.

United statesNew havenSan diegoUnited kingdomSan franciscoSan carlosMarc goodmanReshma kewalramaniAkash tewariJohn maraganoreMaria fardisIovance biotherapeuticsVertex pharmaceuticalsBiohaven pharmaceuticalsDrug administrationAlnylam pharmaceuticals

28 Startups Biotech s Top VC Arch Venture Is Investing in Next

Arch Venture backed 28 startups in 2021, participating in financings ranging from a $3.8 million seed round to a $500 million Series B round.

San diegoUnited statesRecuro healthVenture partnersBi primeVenture capitalArch venture partnersInvestment strategiesInsider healthcareGene editingAllison deangelisAndrew dunn

The FDA just authorized the first pill to treat COVID-19, replenishing the toolkit of treatments against Omicron

A worker at 's manufacturing facility in Freiburg, Germany produces the COVID-19 antiviral pill Paxlovid Pfizer The FDA authorized the first pill to

United statesWhite houseDistrict of columbiaAndrew dunnAllison deangelisKavita patelAlbert bourlaPatrizia cavazzoniEli lillyRegeneron pharmaceuticalsDrug administrationPaxlovid pfizerDrug evaluation

vimarsana © 2020. All Rights Reserved.